Alto Neuroscience, Inc. Skyrocketed
Mon, Oct 20, 2025 at 07:34 PM
Alto Neuroscience, Inc. (ANRO:NYSE) jumped higher at $11, a gain of 80.9%. On Mon, Oct 20, 2025, ANRO:NYSE hit a New 2-Week High of $11. The stock appeared on our News Catalysts scanner on Mon, Oct 20, 2025 at 09:41 AM in the 'PRIVATE PLACEMENT' category. From Mon, Oct 06, 2025, the stock recorded 50.00% Up Days and 45.45% Green Days
About Alto Neuroscience, Inc. (ANRO:NYSE)
Alto Neuroscience is a clinical-stage biopharmaceutical company with a mission to redefine neuropsychiatric care by leveraging neurobiology to develop personalized and highly effective treatment...
Top 10 Gainers:
- Movella Holdings Inc. (MVLA:NASDAQ), 325%
- GSI Technology, Inc. (GSIT:NASDAQ), 155.32%
- Beyond Meat, Inc. (BYND:NASDAQ), 127.7%
- Replimune Group, Inc. (REPL:NASDAQ), 98.78%
- Alto Neuroscience, Inc. (ANRO:NYSE), 80.92%
- Kuke Music Holding Limited (KUKE:NYSE), 49.06%
- 9F Inc. (JFU:NASDAQ), 43.47%
- Kaixin Holdings (KXIN:NASDAQ), 40%
- American Battery Technology Company (ABAT:NASDAQ), 38.56%
- Rani Therapeutics Holdings, Inc. (RANI:NASDAQ), 37.2%